drugset / Trial / NCT04526132
A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A multi-center, randomized, double-blind, placebo parallel controlled phase Ⅲ clinical trial on the efficacy and safety of felbinac trometamol Injection in the treatment of moderate and severe postoperative pain.main purpose is to evaluate the efficacy of Felbinac Trometamol Injection in the treatment of moderate and severe pain after surgery.Secondary purpose is to evaluation the safety of Felbinac Trometamol Injection in the treatment of moderate and severe pain after surgery.
Timeline
- Start
- 2021-04-25
- Primary completion
- 2021-12-29
- Completion
- 2022-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Felbinac Trometamol | Unknown | 8 ml | Intravenous |
Indications
No indication recorded.